The online hub for digital CME and CE courses
The ONA Forum consultants answer your questions
View articles about patient-focused care
The oncology community is well aware that cancer therapy is fraught with increased risk of cardiovascular disease (CVD). Of the almost 12 million cancer survivors in the United States, many are more likely to die of CVD...
The increasing cost of treatments for chronic myeloid leukemia in the United States has reached unsustainably high levels and may be leaving many patients under- or untreated because they cannot afford care.
A new study focused on the vexing problem of how best to handle skin cancers among frail, elderly patients.
Later-stage breast cancers tend to have more mutations and are more heterogeneous than early-stage cancers. Now, new findings demonstrate that heterogeneity is prevalent even within legions of DCIS.
Though researchers have explored which genes are mutated in each type of tobacco-associated cancer, until now no one had thought to look across these types for common genes that might predict patient outcomes.
An irregularity within many neuroblastoma cells may indicate whether a neuroblastoma tumor is vulnerable to a new class of anti-cancer drugs known as BET bromodomain inhibitors.
Presence of the genetic mutation BRAF V600E was significantly associated with increased cancer-related death among patients with papillary thyroid cancer. However, how to use this information to manage mortality risk is unclear.
Researchers presenting at the American Association for Cancer Research Annual Meeting 2013 used easily available canine osteosarcoma samples to discover a novel protein that governs metastasis and chemoresistance in pediatric osteosarcoma.
Taking a break from hormone-blocking prostate cancer treatments once the cancer seems to be stabilized is not equivalent to continuing therapy, a new large-scale international study finds.
April 17, 2013
The key to managing this late effect is patient education because it can manifest long after patients complete radiotherapy.
April 16, 2013
Cancer care entails a confusing labyrinth of screenings, tests, and treatments. This emerging role for nurses is becoming increasingly vital to achieve ideal patient outcomes.
The imaging technique of DTI allows neurosurgeons to visualize important pathways in the brain. This allows them to better adapt brain tumor surgeries and preserve language, visual function, and motor function while removing cancerous tissue.
A mathematical model indicates that lung cancer probably metastasizes in more than one direction at a time, contradicting the traditional view.
African American men on average wait a week longer than their Caucasian counterparts between the initial diagnosis of prostate cancer and treatment, according to a new study.
A new analysis has found that genetic alterations in a particular cellular pathway are linked to bladder cancer risk, recurrence, disease progression, and patient survival. The findings could help improve bladder cancer screening and treatment.
Substantial regional variation in Medicare spending for patients with advanced cancer is not linked to differences in survival, according to a new study.
A new reconstruction technique uses cartilage from behind the ear and skin from the shoulder to repair the nose in one step after skin cancer.
Among patients undergoing surgery for a brain tumor, low T3 (triiodothyronine) syndrome has been found to be predictive of unfavorable clinical outcomes and depressive symptoms.
Surgery offers a better survival benefit for men with localized prostate cancer, according to a large observational study.
The study found that despite the improved survival at high-volume hospitals, the proportion of patients who received multimodality therapy was similar, as it was received by 78% of patients at low-volume hospitals and 79% at high-volume hospitals.
Twenty-three percent of women with newly diagnosed breast cancer reported symptoms consistent with post-traumatic stress disorder shortly after diagnosis. The risk was increased among black and Asian women by more than 50%.
For women undergoing breast reconstruction with implants, most patient-reported outcomes are similar with two different types of silicone gel-filled implants.
Patients with high-risk or relapsed leukemia have been successfully treated with post-stem cell transplantation infusions of large numbers of donor T cells specific for an antileukemic antigen key to prolonging survival, both from the same matched donors.
Therapy to ease stress, fatigue, and other quality-of-life issues significantly improves patients' sense of well-being during cancer treatment, according to new research from a randomized trial.
Researchers have found that a shorter version of a commonly used nutrition-assessment tool effectively helps cancer patients maintain proper nutrition and can potentially improve their outcomes.
Fluorescence form 5-aminolevulinic acid (5-ALA) has been used to guide resection of recurrent GBM. Before surgery, the patient ingests 5-ALA, then the tumor cells fluoresce intraoperatively in response to certain wavelengths of light.
Breast cancer patients who undergo a mastectomy followed by breast reconstruction using a transplanted flap of their own tissue have a low rate of early postoperative complications. However, a new study found that their risk varies by the type of flap procedure they undergo.
The benefits of training in problem-solving skills goes beyond teaching parents to navigate the complex systems that accompany a child's diagnosis of cancer. It also leads to a durable reduction in mothers' levels of anxiety and symptoms of posttraumatic stress, and improves overall coping with a child's illness.
February 22, 2013
A common side effect of cancer treatment, including radiotherapy, is diarrhea. Treatment is based on its cause and severity.
February 22, 2013
A posttreatment assessment of men who underwent treatment for prostate cancer revealed a side effect that has a significant impact on patients.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |
